Cargando…

Ethical issues in competing clinical trials

The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial par...

Descripción completa

Detalles Bibliográficos
Autores principales: Paquette, Miney, Kelecevic, Julija, Schwartz, Lisa, Nieuwlaat, Robby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461579/
https://www.ncbi.nlm.nih.gov/pubmed/31011656
http://dx.doi.org/10.1016/j.conctc.2019.100352
_version_ 1783410499849814016
author Paquette, Miney
Kelecevic, Julija
Schwartz, Lisa
Nieuwlaat, Robby
author_facet Paquette, Miney
Kelecevic, Julija
Schwartz, Lisa
Nieuwlaat, Robby
author_sort Paquette, Miney
collection PubMed
description The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial participation, and patients may be eligible for more than one trial at any given time, selecting the best trial for an individual patient requires evaluation of not only the merits of the individual trials but also patient preferences. This article highlights some potential ethical issues which should be considered when clinical trials are raised as a treatment option and when patients are eligible for more than one trial at the time of evaluation.
format Online
Article
Text
id pubmed-6461579
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64615792019-04-22 Ethical issues in competing clinical trials Paquette, Miney Kelecevic, Julija Schwartz, Lisa Nieuwlaat, Robby Contemp Clin Trials Commun Article The proliferation of clinical trials in the last decade and the relatively limited number of experienced clinical trial sites in comparison has created in some sites an environment of clinical trial abundance. As clinical trial protocols typically restrict patients from concurrent clinical trial participation, and patients may be eligible for more than one trial at any given time, selecting the best trial for an individual patient requires evaluation of not only the merits of the individual trials but also patient preferences. This article highlights some potential ethical issues which should be considered when clinical trials are raised as a treatment option and when patients are eligible for more than one trial at the time of evaluation. Elsevier 2019-04-03 /pmc/articles/PMC6461579/ /pubmed/31011656 http://dx.doi.org/10.1016/j.conctc.2019.100352 Text en Crown Copyright © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Paquette, Miney
Kelecevic, Julija
Schwartz, Lisa
Nieuwlaat, Robby
Ethical issues in competing clinical trials
title Ethical issues in competing clinical trials
title_full Ethical issues in competing clinical trials
title_fullStr Ethical issues in competing clinical trials
title_full_unstemmed Ethical issues in competing clinical trials
title_short Ethical issues in competing clinical trials
title_sort ethical issues in competing clinical trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6461579/
https://www.ncbi.nlm.nih.gov/pubmed/31011656
http://dx.doi.org/10.1016/j.conctc.2019.100352
work_keys_str_mv AT paquetteminey ethicalissuesincompetingclinicaltrials
AT kelecevicjulija ethicalissuesincompetingclinicaltrials
AT schwartzlisa ethicalissuesincompetingclinicaltrials
AT nieuwlaatrobby ethicalissuesincompetingclinicaltrials